Vistogard
About Vistogard:
- Vistogard granules contain the active substance uridine triacetate which is chemically pyrimidine analog.
- Vistogard is used in emergency treatment for overdoses that occur due to fluorouracil or capecitabine or who exhibit early, severe, or life-threatening toxicity that affects cardiac and brain functioning within 96 hours following the discontinuation of fluorouracil or capecitabine administration.
Strength:
Orange-flavored, white-to-off-white oral granules are available in 10 grams packets (95% w/w) used for single-dose.
Recommended Dosage:
- For adults: 10 gms (1 packet) orally every 6 hours for 20 doses, with or without a meal.
- For pediatric: 6.2 gms/m2 of body surface area (dose should not exceed 10 gms per dose) with or without meal.
Important:
- Use a scale to measure the accurate pediatric dose of at least 0.1 gm.
- Vistogard can be administered with 3 to 4 ounces of foods such as apple sauce, yogurt, and pudding and should be ingested within 30 minutes of mixing.
- At least 4 ounces of water should be taken.
- Vistogard granules should not be chewed and if the patient vomits within 2 hours of administration, another dose should be initiated once the patient gets stable.
- If the patient misses a dose, the next dose should be administered at the scheduled time.
- Vistogard can be administered via nasogastric tube or gastronomy tube when required.
Warnings & Precautions: None
Common Vistogard Side Effects
- Vomiting
- Nausea
- Diarrhea
Use in Specific Population
Pregnancy: Limited case reports of Vistogard use during pregnancy are available which is insufficient to claim a drug-associated risk of birth defects or miscarriage.
Pediatric use: The safety and effectiveness of Vistogard have been established in pediatric population and the clinical response and safety in adult and pediatric patients were similar, however, the clinical data are limited.
Storage and Handling
- Vistogard granules must be stored at room temperature which is USP controlled, 25°C (77°F)
- Excursions are permitted to 15° to 30 °C (59° to 86°F).
For the medicine procurement, we follow a simple four-step process.
- Enquiry about the medicine: When you request information about the medication you require, we will handle your data. Our Named Access Program Support team will contact you within 24 hours to assist.
- Verification Process: In our mission to help patients access medications that may not be approved or readily accessible in their home countries, Sansfro ensures the verification of medicine availability and approval. Additionally, we thoroughly review the patient’s prescription and medical information for accuracy and compliance.
- Sourcing the Medicine: Upon successfully completing the verification process, our team will initiate contact with our network of suppliers to source the required medication for you. Subsequently, our team works diligently to obtain the most favorable quotes for your medicines and oversees the processing of your order.
- Safe Delivery: We will coordinate the secure delivery of your consignment upon approval of the final quote. Our team of logistics specialists is available to provide consignment tracking assistance. Acknowledging that the Named Access Program industry is susceptible to unauthorized channels is essential. To uphold the safe and legal provision of medications, we rigorously adhere to Standard Operating Procedures.
For the importation of medication, we will require the following documents from the patient:
- An authentic prescription copy.
- A proof of identity document.
- Information about the healthcare provider in charge.
- A current residential address.
Once all these documents are provided, the Sansfro team will begin the import license application process. This license is a crucial requirement to facilitate the procurement of the necessary medication upon receiving government approval.
No news found.
About Sansfro
Sansfro is committed to bridging the healthcare gap. Our purpose is to bring hope and healing to patients suffering from rare diseases by linking them with life-saving treatments through our Named Patient Program. Join us in our quest for a better and healthier world.
Know More...FAQ'S
What are the active ingredients of Vistogard?
Vistogard contains Uridine triacetate as an active substance.
How Vistogard is stored
Store Vistogard at room temperature between 68◦F to 77◦F (20◦C to 25◦C)
What are the possible side effects of Vistogard?
- Vomiting
- Nausea
- Diarrhea
Which indication Vistogard is used for?
Vistogard is a prescription medicine that contains uridine, a substance that is normally found in your body. It is used for emergency treatment of adults and children after an overdose of fluorouracil or capecitabine with or without symptoms, or who have early signs of severe or life-threatening side effects that affect the heart, or early signs of severe or life-threatening neurologic problems, or certain unusually severe side effects within 4 days (96 hours) after receiving treatment with fluorouracil or capecitabine.
What is price of Vistogard in India?
For enquiry related to Vistogard price kindly reach out to our Patient Support Team at (+91) 9315705373 or help@sansfro.com
Dr Anchal Aryan
Medical counselor
Patient Stories
Word Wide Delivery:
India, Andorra, Argentina, Australia, Austria, Azerbaijan, Bahrain, Brazil, Bulgaria, Cambodia, Canada, Chile, Colombia, Costa Rica, Croatia, Cyprus, Denmark, Dominican Republic, Estonia, Finland, France, Georgia, Germany, Ghana, Greece, Guatemala, Iraq, Ireland, Israel, Italy, Jamaica, Japan, Jordan, Kenya, Kuwait, Latvia, Lebanon, Libya, Lithuania, Malawi, Mexico, Montenegro, Nepal, Netherlands, New Zealand, Nigeria, Norway, Oman, Pakistan, Paraguay, Peru, Poland, Qatar, Romania, Saudi Arabia, Serbia, Singapore, Slovenia, Spain, Sri Lanka, Sweden, Switzerland, United Arab Emirates, United Kingdom, United States, Venezuela, Zimbabwe, Afghanistan, Albania, Algeria, American Samoa, Angola, Anguilla, Antarctica, etc.
